Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

3.670 +0.320 (+9.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ENDRA Life Sciences Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why ENDRA Life Sciences (NDRA) Stock Is Up 140%
ENDRA Life Sciences shares are trading higher by 147% Tuesday. The company announced the activation of a post market clinical study of the TAEUS liver system. 
Via Benzinga
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar. 
Via Benzinga
Data I/O And 2 Other Stocks Under $5 Executives Are Buying
Via Benzinga
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
US Stocks Mixed; Lowe's Cuts FY24 Forecast
Via Benzinga
Crude Oil Down 2%; Zoomcar Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Dow Jumps 75 Points; US Consumer Confidence Surges In August
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Edge Lower; Applied Materials Earnings Top Views
Via Benzinga
ENDRA Life Sciences Announces Reverse Stock Split
From ENDRA Life Sciences Inc.
Via Business Wire
NDRA Stock Earnings: ENDRA Life Sciences Misses EPS for Q2 2024
NDRA stock results show that ENDRA Life Sciences missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Announces Leadership Changes
From ENDRA Life Sciences Inc.
Via Business Wire
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14
From ENDRA Life Sciences Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.